Balamuthia mandrillaris: Difference between revisions

From IDWiki
Balamuthia mandrillaris
()
()
 
(2 intermediate revisions by the same user not shown)
Line 1: Line 1:
==Background==
==Background==
===Microbiology===
===Microbiology===

* One of the [[free-living amoebae]]
*One of the [[free-living amoebae]]


===Epidemiology===
===Epidemiology===
* Present in soil
* More common in US and South America
* More common in Hispanics


*Present in soil
==Clinical Presentation==
*More common in US and South America
* Causes '''granulomatous amebic encephalitis (GAE)''' alone, skin lesions followed by GAE, or (rarely) skin lesions alone
*More common in Hispanics
** Characterized by progressive hemorrhagic necrosis of brain, with 90% mortality

** Fever, headache, altered mentation), vomiting, lethargy, seizures, and weakness
==Clinical Manifestations==
* Often preceded by skin lesions by a few weeks to 2 years

** Typically affect the nose and cheeks, but also torso and limbs
*Causes '''granulomatous amebic encephalitis (GAE)''' alone, skin lesions followed by GAE, or (rarely) skin lesions alone
** Often a single lesion
**Characterized by progressive hemorrhagic necrosis of brain, with 90% mortality
** Progress over months from papulonodular erythematous plate-like areas, enlarging and eventually ulcerating
**Fever, headache, altered mentation, vomiting, lethargy, seizures, and weakness
** Typically painless
*Often preceded by skin lesions by a few weeks to 2 years
* Can also initially present with rhinitis, sinusitis, or otitis media
**Typically affect the nose and cheeks, but also torso and limbs
* Difficult to treat, with high mortality
**Often a single lesion
**Progress over months from papulonodular erythematous plate-like areas, enlarging and eventually ulcerating
**Typically painless
*Can also initially present with rhinitis, sinusitis, or otitis media
*Difficult to treat, with high mortality

==Management==


*Based on case reports
*Combination therapy recommended by CDC:
**[[Is treated by::Pentamidine]] 4 mg/kg IV once daily
**[[Is treated by::Sulfadiazine]] 1.5 g PO q6h
**[[Is treated by::Flucytosine]] 37.5 mg/kg PO q6h
**[[Is treated by::Fluconazole]] 12 mg/kg PO/IV once daily
**[[Is treated by::Azithromycin]] 20 mg/kg (max 500 mg) PO once daily (or [[Is treated by::clarithromycin]]
**[[Is treated by::Miltefosine]] 50 mg PO tid (if ≥45 kg) or bid (if <45 kg)
{{DISPLAYTITLE:''Balamuthia mandrillaris''}}
{{DISPLAYTITLE:''Balamuthia mandrillaris''}}
[[Category:Protozoa]]
[[Category:Protozoa]]

Latest revision as of 13:09, 17 September 2020

Background

Microbiology

Epidemiology

  • Present in soil
  • More common in US and South America
  • More common in Hispanics

Clinical Manifestations

  • Causes granulomatous amebic encephalitis (GAE) alone, skin lesions followed by GAE, or (rarely) skin lesions alone
    • Characterized by progressive hemorrhagic necrosis of brain, with 90% mortality
    • Fever, headache, altered mentation, vomiting, lethargy, seizures, and weakness
  • Often preceded by skin lesions by a few weeks to 2 years
    • Typically affect the nose and cheeks, but also torso and limbs
    • Often a single lesion
    • Progress over months from papulonodular erythematous plate-like areas, enlarging and eventually ulcerating
    • Typically painless
  • Can also initially present with rhinitis, sinusitis, or otitis media
  • Difficult to treat, with high mortality

Management